[Urodilatin (INN: ularitide). A new peptide in the treatment of acute kidney failure following liver transplantation].

@article{Kuse1996UrodilatinU,
  title={[Urodilatin (INN: ularitide). A new peptide in the treatment of acute kidney failure following liver transplantation].},
  author={E. R. Kuse and Markus Meyer and Raluca Constantin and K. -J. Oldhafer and Hans J. Schlitt and Peter Schulz-Knappe and H J Uberbacher and Rudolf Pichlmayr and Wolf Georg Forssmann},
  journal={Der Anaesthesist},
  year={1996},
  volume={45 4},
  pages={351-8}
}
UNLABELLED Acute renal failure (ARF) is a serious complication following liver transplantation. Many therapeutic regimens have been used so far but with limited success. Urodilatin (URO) is a new member of the atrial natriuretic peptide (ANP) family. When administered intravenously, URO induces strong diuresis and natriuresis with tolerable hemodynamic side effects. Preliminary non-controlled clinical studies demonstrate beneficial effects using URO as a therapeutic agent in patients suffering… CONTINUE READING